ennl

The administration of eye drops was never so easy

What is Eyot®?

The Eyot® is a plastic eye drop aid which is suitable for plastic eye drop bottles and plastic eye gel tubes as well as the Single Unit Dose packaging (Minims).

The Eyot® supports the patient in two ways:

  • The Eyot® helps the patient bring the eye drop bottle or eye gel tube or Minim into the correct position in front of the eye.

  • By looking straight up at the ceiling through the window in the Eyot®, the head is tilted backwards into the correct position.

The Eyot® has an acceptable consumer price and is user-friendly.

The Eyot® is available in two models from Dutch pharmacies; Eyot® Red and the Eyot® Minim. Eyot® products are also sold by various pharmaceuticals companies under their own brand names.

Read more about Eyot®

De-Eyot®-met-doosje

Research and test experience show that it is difficult to put eye drops into your own eye. Most patients experience the following problems when administering eye drops:


  • Insufficient support for the bottle
  • Shaking
  • Restricted vision
  • Hard to position the bottle, resulting in the drop falling beside the eye
  • Fear that the bottle will touch the eye
  • Difficulty squeezing the bottle
  • Not always possible to tilt the head backwards to a horizontal position
  • Not always possible to squeeze the bottle if the hand is not aligned with the wrist and arm
  • Patients often nervous if it is the first time they are administering eye drops
  • > Read more about Eyot®

Finally, the point at which the drop enters the eye is important. A general rule is that the drop should be administered to the lower conjunctival sac (lower inner eyelid). The lower conjunctival sac has a very small surface area. The patient must aim very accurately in order to get the eye drops into the conjunctival sac.

Interested in the Eyot®?

Start using this simple and effective eye drop device now!
Click below to find out where to get your own Eyot®

User friendly
Tested in hospitals and pharmacies
Good value for money
Supported by clinical trials